Clinical Collection on Rheumatic Diseases

Program composed of 4 lessons in e-learning format. As a clinician, you will learn new advances in research on rheumatic diseases.

In this edition we want rheumatologists who sign up for the course to be able to:

• To understand the relationship between the use of opioids and non-steroidal anti-inflammatory drugs (NSAIDs) in patients with RA, focusing on adverse cardiovascular events and mortality. 
• To analyze the clinical and radiographic results of a clinical trial comparing certolizumab pegol, abatacept, tocilizumab and active conventional treatment in patients with recent-onset RA.
• To explore the complex role of estrogens in the risk and severity of RA at menopause.
• And to investigate the prevalence and clinical characteristics of patients with RA and interstitial lung disease using care data unstructured medical and machine learning.

In summary, novel topics and approaches that will give rheumatologists food for thought.

By completing the course you will be able to obtain course credits from the National Health System (only for doctors practicing in Spain).

Dates: 21/10/2024 – 31/05/2025
X,X credits (8 teaching hours)
Credits have been requested from the National Health System.
Registration number: 09/038258-MD

V1 N5: Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events (2h. teaching hours)

V1 N6: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis (2h. teaching hours)

V1 N7: Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis (2h. teaching hours)

V1 N8: Polygenic risk score: the potential role in the management of systemic lupus erythematosus (2h. teaching hours)